• House Select Committee unveils climate plan involving nuclear energy as essential in clean electric-energy production
• Global uranium prices have risen 34% since March 1 amid significant production cuts
• Energy Fuels uniquely positioned as leading U.S. uranium producer and recycler, set to capitalize on growing nuclear energy role

As the largest uranium miner in the United States, Energy Fuels (NYSE American: UUUU) (TSX: EFR) is poised to capitalize on the government’s recent push for nuclear energy. On June 30, the U.S. House Select Committee on the Climate Crisis released an action plan titled “Solving the Climate Crisis: The Congressional Action Plan for a Clean Energy Economy and a Healthy, Resilient, and Just America” that calls for net-zero greenhouse gas emissions by 2050, and net-negative emissions after that (http://ibn.fm/TcRfx). In addition, the committee’s detailed plan notes that Congress should establish a national clean-energy standard that encourages zero-emission carbon technologies — such as nuclear — to achieve net-zero emissions in the electricity sector by 2040 Recognizing that a substantial reduction in greenhouse gas emissions of the electrical energy sector is needed to minimize the effects of climate change, the report highlights nuclear power as the largest source of carbon-free energy in the country. As such, nuclear energy has an essential role in confronting the global climate challenge. Nuclear facilities are not only emissions free, but they are also the most reliable assets in the power generation mix, operating under circumstances often requiring fossil fuel and renewable energy plants to cease or curtail their operations, such as extreme weather conditions. As the country’s leading uranium and vanadium producer, Energy Fuels is well positioned to capitalize on the growing demand for clean energy. Energy Fuels has also recycled over 6 million pounds of uranium from its alternate feed recycling program. The carbon-free electricity produced from this recycled uranium would be the equivalent of a train full of coal that stretched from Los Angeles to New York — and back again — thereby avoiding 85 million tons of CO2 emissions.  Among clean-energy options, nuclear is recognized as one of the most reliable, affordable and stable, contributing to 55% of all clean-energy production throughout the country in 2019 (http://ibn.fm/JUuM2). In terms of carbon emissions and air pollution reduction, Energy Fuels is one of the greenest companies operating in the U.S. As the push for clean energy gains momentum, the global market shows signs of imbalance with global demand for uranium ore concentrate estimated to exceed production by 1 billion pounds over 2019–2040. Reflecting an international surge in nuclear power activity, global uranium prices have been improving globally with a 34% increase since March 2020 amid significant production cuts due to COVID-19 (http://ibn.fm/vQGGm). The global boost for nuclear energy, combined with the declared U.S. national policy to revitalize the nuclear sector and preserve domestic infrastructure to regain U.S. global nuclear leadership, distinguishes Energy Fuels, the country’s top producer of uranium, as a clear leader in the space. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• With CO2 extraction, consumers benefit from premium-quality, full-spectrum oil (“FSO”) with no toxic byproducts
• Pure Extract is also focusing on mushrooms because of the myriad of health benefits consumers are experiencing

Pure Extract, a private, plant-based extraction company with a new vertical in functional mushrooms, is committed to providing the highest-quality products possible. With that in mind, the company relies on CO2 extraction, a process based on pressurized carbon dioxide that provides some of the cleanest, healthiest products available on the market today.

Methods of mushroom extraction, or the process of releasing and concentrating compounds for medicinal dosages, vary. With that in mind, one of the primary benefits of using an extract from CO2 extraction is its status as a “green solvent” (http://ibn.fm/TGlE3).

CO2 extraction “provides a cleaner and healthier product,” reports an article titled “Your Concise Guide to CO2 Extraction: What It Is and Why You Need It,” published by Premium Jane. “We produce CO2 naturally as part of the breathing process when we exhale. Unlike solvents such as butane, CO2 extraction contains no nasty chemical residues. It is also recyclable and cost-effective,” the article states.

The article goes on to explain that CO2 extraction uses pressurized carbon dioxide to take as many desirable components from the plant — or mushroom — as possible. “Manufacturers use carbon dioxide because it is a versatile, ‘tunable’ solvent. It acts as a solvent at a specific temperature and pressure range. However, it doesn’t have the dangers associated with solvents. As a result, consumers benefit from a premium-quality, clean oil with no toxic by-products,” the article notes.

Pure Extract is committed to becoming one of the dominant extraction companies in the industry and a leader in the rapid development and commercialization of functional mushroom products. The company is currently focused on mushrooms because, as one report noted, “the prospects of antiviral, antibacterial, and anticancer properties are too powerful to cast aside. And as clinical research evaluates medicinal and psychedelic mushrooms, the importance of active product ingredient extracts amplifies, given the need to sort out what each molecule can do” (http://ibn.fm/EeHog).

Pure Extract’s Vitalis C02 extraction technology allows for full-spectrum oil extraction, which results in the purest, highest-quality oil. In addition, the company, which notes that “extraction is our business,” will soon have the  capacity for more than 100,000 kg of biomass per year with a technique that has been tried and tested through its teams’ industry experience (http://ibn.fm/ohQl6).

The functional mushroom industry is among the fastest growing in North America, with forecasts predicting the global medicinal mushroom market will grow annually by $13.88 billion (http://ibn.fm/npEn8). As the industry transitions from dry biomass to extracts, many companies are unprepared for this new opportunity.

Pure Extract, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located near Whistler, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production of high-quality, high-purity formulations on a commercial scale.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

• The company was named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors
• Global digital diabetes management market is projected to register CAGR of 17.8% by 2026
• DarioHealth’s platform lauded for centering on continual maximization of patient engagement

DarioHealth (NASDAQ: DRIO), a global digital therapeutics company serving its users with dynamic mobile health solutions, is in the spotlight as a major global player in the digital diabetes management market.

A recent report published by Data Bridge Market Research featured DarioHealth and its advancements in digital diabetes management – a growing global market expected to become the “next best thing” in the wake of the current coronavirus pandemic that has made it more difficult for diabetes patients to receive treatment. The market is projected to register a CAGR of 17.8 percent by 2026.

Digital diabetes management devices are used to self-monitor blood glucose levels. The technology combines diabetes monitoring hardware and mobile software with cloud computing infrastructure. Smart glucose monitors are wireless monitors that provide information about blood glucose data directly to your mobile device.

With 4.9 stars on the Apple App Store and 11,000 reviews, Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is a popular product with over 50,000  consumers around the globe. With a powerful commitment and contribution to chronic condition management through innovative digital therapeutic solutions, including a novel method for chronic disease data management, the company is rapidly moving toward addressing new chronic conditions and into new geographic markets.

The company was also named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors on July 2, 2020 (http://ibn.fm/1BNMs).

Matheis brings to the DarioHealth Board nearly 30 years of experience leading regional and national health care plans and related organizations (http://ibn.fm/TIAVk). He currently serves as President of Optima Health, a division of Sentara Healthcare which has more than 850,000 members and a network of over 26,000 providers.

“Over the course of my health care career, I have seen first-hand how even modest behavior changes can positively impact the long-term health of people suffering from costly and in some cases debilitating chronic medical conditions,” stated Matheis. “I have been aware of Dario for some time now, and I believe the company’s highly engaging user platform sets the company apart and provides tangible results for patients and demonstrated savings for payers.”

According to CEO Erez Raphael, Matheis will leverage his experience to aid DarioHealth in its transition to a business-to-business-to-consumer model, serving people suffering from chronic diseases via direct relationships with health plans, large employers, and benefits administrators.

The company was also cited in a recent article about patient engagement that emphasizes Dario platform’s continual maximization of patient engagement through personalization, including “nudges” and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices (http://ibn.fm/Bdh0s).

The report further underlines that health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs that encourage patients to be more involved in managing their conditions, and proactively take preventative measures that reduce risk, emergency room visits, and preventable hospitalization.

With personalized, mobile health solutions, DarioHealth provides more control and greater independence for people with chronic conditions as they work to manage their daily challenges, empowering individuals to make healthy adjustments to their lifestyle choices and improve their overall health.

For more information, visit the company’s website at www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

• Today’s consumers are increasingly moving towards online automotive transactions for increased efficiency and safety
• PowerBand Solutions continues to deploy its comprehensive virtual platform for buying and leasing automobiles online via home computers or handheld smart devices
• The company’s platform enables seamless sales transactions by including responsiveness to financing, inventory and inspections

The world is becoming more connected every day. Devices have the ability to collect and exchange data points in an ecosystem of smart devices without human involvement. Between 2015 and 2025, those data points are expected to experience a five-fold increase (http://ibn.fm/7XZOO).

This is great news for the automotive industry, and PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), which is emerging as the leader in online vehicle transactions using smart phones.  With more touch points, companies can better understand consumers, their needs and their buying habits. From there, messaging and processes can be increasingly customized and effective in engaging consumers. For progressive automotive companies, this improved access will create more opportunities to collect information about consumers, provide them with a more convenient purchasing experience, and drive engagement accordingly.

Disruptive fintech innovator PowerBand is leveraging the advancements in technology to drive its smart-tech-accessible platform to obtain household name status as a preferred means of buying and leasing automobiles. The platform offers a personalized online purchase journey capable of addressing any concerns that may arise between listing and sale with success rates not possible with other online services.

The automotive industry has been in a state of flux, with every aspect experiencing disruption from driverless vehicles to artificial intelligence. Customer expectations continue to become increasingly sophisticated as technological innovations progress. As more customers begin to expect the seamless digital service they receive in other retail markets, the automotive industry must adapt to remain competitive and protect profits as well as finance and insurance margins. To do so, retailers must find opportunities to leverage the digital-oriented nature of buyers and their desire for advanced technology. The automotive industry and consumers are both responding quickly to take advantage of the added convenience.

With the coronavirus continuing to surge in many areas throughout the United States, consumers are seeking online transactions in every market in order to limit face-to-face interaction. Buying a car sight-unseen sounds daunting, but today’s consumers seem to have absolutely no problem doing so. According to the ‘Digital Commerce 360 Online Vehicle Shopper 2019’ survey, conducted among 1,089 buyers, 49% are willing to purchase a new vehicle entirely online (http://ibn.fm/2Rt8i). According to Frost & Sullivan, consumers may purchase as many as 1.3 million vehicles annually online as soon as 2035 (http://ibn.fm/q3Nmq).

Even more traditional legacy manufacturers like Honda are getting on board. The auto giant recently decided to pre-sell its Limited-Edition Civic Type R “hot hatch” entirely online. The virtual order books opened up 1 p.m. and by 1:04 p.m., all 100 build slots were taken. Each reservation required a $1,000 deposit. And Honda has yet to announce the final price for the car (http://ibn.fm/wVmZ7).

PowerBand Solutions is uniquely positioned to experience this silver lining of the crisis. The company’s innovation in providing a highly effective online trading alternative attracted Texas-based D&P Holdings, Inc., one of the largest administrators of automotive warranty and insurance products in the United States. D&P made a $6 million direct investment in the company and has stated it intends to invest $10 million eventually.

“While COVID-19 has caused unexpected business delays for many of us, this crisis has reinforced our belief that PowerBand will revolutionize how consumers and dealers interact when they buy, sell, lease and trade cars and trucks,” D&P CEO John Armstrong stated in April (http://ibn.fm/FqfE3).

PowerBand’s platform digitizes not only the transfer of money, but also the financing and inventory paperwork, vehicle inspections, and auction negotiations. The streamlined platform provides a speed, ease, and cost-efficiency in automotive sales that is expected to dramatically impact the industry.

For more information, visit the company’s website at www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

• Sleep apnea devices market growth also driven by the current pandemic which has made it exponentially more difficult for patients to seek treatment for their condition
• Registered with the FDA as a Specification Developer, Vivos develops and markets the first non-surgical, non-invasive and cost-effective solution for the estimated billion of people globally who suffer from OSA
• Vivos believes its proprietary system is poised to provide the most significant breakthrough in OSA treatment since CPAP

The global sleep apnea market is expanding rapidly, being expected to reach $13.24 billion by 2027, from $7.81 billion in 2019, exhibiting a CAGR of 6.8 percent. In a report titled “Sleep Apnea Devices Market Size . . .”, Fortune Business Insights notes that the rising cases of cardiovascular disorders and diabetes among the geriatric population are some of the primary causes of the surge in sleep apnea (http://ibn.fm/wlVz2). Additionally, a reduction in polysomnography, laboratory-based CPAP (Continuous Positive Airway Pressure) and bi-level therapy can cause a decline in diagnosis of new sleep apnea cases as well as exert a negative impact on the growth of the market. Moreover, the report cites NCBI data indicating a 50 percent decline in compliance rates for CPAP devices. This has created the need for alternative oral appliances to provide comfort to sleep apnea patients.

An emerging global leader in the treatment of obstructive sleep apnea (“OSA”), Vivos Therapeutics, Inc. is uniquely positioned to capitalize on this growing market and the increased demand for sleep apnea alternative solutions. The company’s proprietary Vivos System(R) is the first treatment modality for mild to moderate OSA in adults that does away with the need for lifelong interventions. The system’s treatment time is a fraction of that of its alternatives, potentially offering patients lasting relief in a matter of months, eliminating the need for surgery (http://ibn.fm/xdHWd).

The leading cause of OSA is a deficiency in the development of craniofacial anatomy. Pneumopedics  is the natural process introduced by Vivos biomimetic technology where the airway tissues are remodeled resulting in enhanced capacity over the course of treatment, which typically ranges from 18 to 24 months. Unlike many other approaches, it aims for a lasting resolution by targeting the root cause of sleep apnea.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated one billion people worldwide who suffer from OSA. Vivos Therapeutics believes its technology represents the most important breakthrough in OSA treatment since CPAP, which involves the use of special face or nasal masks.

The company’s oral appliances have proven to be effective in more than 15,000 patients successfully treated worldwide by approximately 1,350 trained dentists. Vivos’ vision is to provide clinicians with the tools to provide the best alternative solution to treat OSA.

For more information, visit the company’s website at www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics are available in the company’s newsroom at http://ibn.fm/VVOS

• The need for efficient drug procurement and delivery has never been more in demand
• Trxade Group’s unmatched supply chain trading platform represents a unique portal to speeding up drug distribution
• Such efficiencies are key to improving margins and keeping America’s independent pharmacies alive

Not in recent memory have medical services and associated support personnel been viewed as more vital to the nation. Just as indispensable, but not as visible, are the supply chain channels through which medical supplies flow, for doctors without medicines may be so handicapped as to be useless. So too would be pharmacies where the bulk of medicines are dispensed. As a result, it is crucial that these supply chain channels operate efficiently.

One company has been working specifically toward that end. Trxade Group (NASDAQ: MEDS) has developed an integrated drug procurement and delivery platform that is improving supply chain and market efficiency, speeding up distribution of drugs while also ensuring critical transparency on prices. This is good news for independent pharmacies; direct dealing on the platform will lead to improved margins. And consumers will undoubtedly welcome the platform’s price discovery capabilities. The Trxade digital pharmaceutical exchange is set to shakeup the staid drug distribution business.

Trxade’s web-based platform has something for everyone. Patients will benefit from the lower prices its algorithms identify, while pharmacies are now more likely to avoid negative reimbursement costs, which flatten profit margins. Close to half the number of independent pharmacies operating across the nation are registered users on the Trxade platform. The company expects 2019’s signup rate—8 or 9 new pharmacies every day—to continue throughout 2020. There is good reason for those expectations. For a long time, America’s independent pharmacies haven’t been getting a good deal.

The U.S. pharmaceutical industry is a sprawling system made up of around 65,000 pharmacies. Most are branches of the large chains. A recent report provides a snapshot of the landscape (http://ibn.fm/cfPqA). CVS Pharmacy, the largest, employs 18,631 pharmacists in close to 9,105 stores. Walgreens has 17,437 pharmacists working in its 7,713 or so stores, while Rite Aid with its 4,515 stores employs 9,194 pharmacists. Walmart has less stores (4,403) than Rite Aid but employs more pharmacists (10,458). This colossal operation moves around $330 billion worth of pharmaceuticals per annum. But most of the business goes to the giant chains with their thousands of retail outlets and their ability to capture significant excess margin at the cost of the consumer, employers and government.

This leaves about one-third of the nation’s pharmacies that are run independently, that do not belong to a large corporate chain. These smaller independent pharmacies tend, on average, to be $3.5 million-per-annum enterprises owned and managed, typically, owner operated vocational pharmacists. Predictably, they struggle to stay afloat, surviving on thin margins that continuously pose an existential threat.

The presence of pharmacy benefit managers (“PBMs”) hasn’t really helped. These third party administrators of prescription drug programs were expected to reduce the purchase costs of drugs across the board and they have but the benefits have accrued to a select few. The three largest PBMs— Caremark (CVS Health) / Aetna, Express Scripts, OptumRx (UnitedHealth)—now control 76 percent of the market. And, as the Brookings Institution has pointed out in testimony to Congress, “health care markets are becoming more consolidated, causing price increases for purchasers of health services…” (http://ibn.fm/LeLbP).

However, Trxade’s pharmaceutical platform gives independent pharmacies a real shot at reducing their purchasing costs, and much more. The integrated pharmaceutical services company offers not just a web-based purchasing platform for transactions between independent pharmacists and drug distributors (“B2B”), but a network of associated pharmacies with its E-Hub software, and a mail order pharmacy, as well as warehouse and drug delivery services.

Called the Trxade Exchange, the platform gives small pharmacies access to the wider pharmaceutical distribution network, allowing them to search for and view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. Trxade is hoping that the majority of America’s 24,000 independent pharmacies, who which together have a combined annual purchasing power of over $92 billion, will eventually see how Trxade’s supportive platform that can make their businesses more profitable.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• ISWH CEO reports strong organic growth in home healthcare division
• Company “most excited” about revolutionary solution designed to provide home-health patients with simple, one-button, wearable device to summon help
• TeleCare allows patients to maintain greatest level of independent existence while still accessing care they need

ISW Holdings (OTC: ISWH), a brand-management portfolio company with diverse partnerships, looks to be particularly astute at recognizing growing businesses in multiple sectors. The company has partnerships in crypto mining, renewable energy, wellness and restoration, and the adult-beverage industry, as well as early-stage operations in supply chain and logistics management. Most recently, the company has announced it is launching its proprietary telecare technology service as part of its successful and growing home healthcare business (http://ibn.fm/I8mHJ).

Noting that the company is making tremendous strides toward integrating telehealth services into its home healthcare division — Paradigm Home Health — ISWH president and chairman Alonzo Pierce reported strong organic growth in the space, “with sequential monthly topline expansion in place now for five consecutive quarters and counting.”

“Our TeleCare service is one of the initiatives we are most excited about right now,” he continued in a letter to ISWH shareholders. “This is a new technology solution we are preparing to launch as part of our home healthcare service. TeleCare is a revolutionary technology solution designed to provide home-health patients with a simple, one-button wearable device to quickly and easily summon a visiting nurse, home-health provider, or 24/7 nurse-assist hot line anytime medical assistance is urgently needed.”

The technology works like a nurse-call button in a hospital. “Our research suggests this will create tremendous additional value and enhance our clients’ lives by helping them to maintain the greatest possible level of independent existence while still having access to the supportive care they need,” Pierce observed.

The timing for the technology releases looks to be ideal. ISW Holdings is introducing the technology solution in the wake of recent steps taken at the federal level to deregulate telehealth in response to the COVID-19 pandemic health crisis. “Our sense is that this new strong momentum towards telehealth solutions is going to be sticky,” Pierce said. “In other words, the pandemic spurred a transition, and it’s going to be impossible to put the genie back in the bottle afterwards. Companies that fail to embrace the future risk being left behind.”

Recognizing possibilities and embracing opportunity is at the heart of what ISWH is about. This newest move is part of the company’s overarching strategy to create companies and partnerships in disruptive industries. The use of innovative products and services is key to anticipating the future needs of the markets in which the company serves. “ISW is determined to embrace new solutions and implement more efficient and effective strategies to provide our clients, customers, and shareholders with every inch of edge we can muster,” Pierce concluded. “And our new TeleCare solution exemplifies that determination.”

For more information, visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• PowerBand Solutions subsidiary MUSA Auto Finance, LLC, has secured an agreement with a national depository financial institution that provides the online auto leasing platform with $300 million for transactions
• PowerBand Solutions is building an innovative smart tech platform that streamlines the transfer of money and paperwork associated with financing and inventory, vehicle inspections and auction negotiations
• The remote-access tech solution provides a timely response to the COVID-19 pandemic, which has been responsible for governmental policies worldwide restricting in-person group gatherings
• Despite the reach of the pandemic, Americans’ desire for getting out on the country’s roads during the summer remains high, with some 700 million trips forecast during the season, 97 percent of which would be by automobile

Disruptive fintech innovator PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) announced July 13 that its U.S. leasing division, MUSA Auto Finance, LLC, have begun originating auto loans in Texas and Florida and will soon add California and other states’ markets after gaining $300 million in lease financing from a federally chartered U.S. depository financial institution for its online leasing platform (http://ibn.fm/O9wIq).

The $300-million funding agreement with the national financial institution opens the door for PowerBand to expand its future lending facilities, allowing customers and dealers to use their smart phones or other digital devices to buy, lease, and finance vehicles on PowerBand’s innovative new platform as easily as they buy products through web-based retailers such as Amazon.

The AAA 2020 Summer Forecast Report issued recently by the renowned auto club group predicted that Americans would take 700 million trips this summer, 97 percent of which would be by car due to low gasoline prices and lingering wariness of the shared confines inherent in plane travel. “You have that comfort of being in your own vehicle,” Mark Jenkins, spokesman for AAA, stated in a Tampa Bay Times report (http://ibn.fm/stndu). “You know how clean it is, and you know who you’re traveling with.”

National unemployment rates have remained in the double digits even though they have declined from their April peak of 14.7 percent, representing nearly 18 million people who may have more than the usual amount of free time on their hands while buoyed by pandemic-inspired national economic stimulus programs (http://ibn.fm/h5IV8).

The auto loans launching under PowerBand Solutions’ subsidiary are providing Americans with timely solutions for their driving and financing needs amid the pandemic as an alternative to physical in-person purchasing. MUSA’s platform calculates a lease on a loan application, uses AI functions to automatically render a decision on the application and provides approval to dealer partners when applicable, profiling the lease contract in the process. Approvals can occur in seconds.

“Our strategy is to aggregate further funding facilities in the weeks and months ahead, to offer multi-billion-dollar financing opportunities to consumers and dealers using our platform in the United States and Canada,” PowerBand CEO Kelly Jennings stated in the announcement. “We are looking forward to finally offering our products to our many partners in the automotive sector and millions of consumers in the coming months across North America.”

PowerBand Solutions’ platform streamlines not only the transfer of money and paperwork associated with financing, but also inventory paperwork, vehicle inspections and auction negotiations — all without requiring direct in-person contact that might put a buyer or seller at risk of infection while the pandemic’s transmission rate remains high.

The pandemic’s lasting effect on the economy has yet to be fully calculated, but even if infection rates continue to rise once North America descends into a colder winter season appliances and generally essential goods such as automobiles are likely to remain in demand (http://ibn.fm/1olBD).

PowerBand’s platform is a forward-thinking solution that expects to distinguish itself as an example of American innovation in business during the most difficult of market conditions. MUSA was awarded a contract by Tesla Motors to become a national leasing partner in 2018 as a show of confidence in MUSA’s proprietary technology.

For more information, visit the company’s website at www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

• Clinical studies show serotonergic psychedelics may be effective in treating anxiety, depression, addiction and more
• Interest in serotonergic psychedelics has dramatically increased within last decade
• Cybin Corp. is focused on furthering research, development of psilocybin-based medications through Serenity Life Sciences Inc.

For decades seen as a taboo substance, psychedelics today are being viewed in a powerful new light. This significant societal switch is based, at least in part, on credible clinical studies, which have shown that serotonergic psychedelics may be effective in treating anxiety, depression, addiction and even cancer (http://ibn.fm/mSzY5). Cybin Corp., a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products as well as the functional mushroom market, appears to be a strong player in this developing new space.

“Scientific interest in serotonergic psychedelics . . . has dramatically increased within the last decade,” reported a recent article published by the American Society for Clinical Pharmacology and Therapeutics. “Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in treating anxiety and depression, as well as addiction to tobacco and alcohol. Moreover, recent research has suggested that these compounds have potential efficacy against inflammatory diseases through novel mechanisms, with potential advantages over existing antiinflammatory agents. . . .

“Antiinflammatory effects may hold promise for efficacy in treatment of inflammation-related nonpsychiatric as well as potentially for psychiatric disorders,” the article, which was titled “Psychedelics as Medicines: An Emerging New Paradigm,” stated. “Serotonergic psychedelics operate through unique mechanisms that show promising effects for a variety of intractable, debilitating, and lethal disorders, and should be rigorously researched.”

This research has fueled growth in an industry based on psychedelic medication, a space where Cybin Corp. is emerging as a leader. The company is focused on furthering research and development of psilocybin-based medications through its wholly owned division, Serenity Life Sciences Inc. Psilocybin is a naturally occurring, non-habit-forming psychedelic compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Cybin is committed to its mission of bringing “fungi-derived psychedelic and medicinal products into the world that may potentially drive the next discovery phase of life-changing medications to treat mental illness and other health conditions.” With that mission in mind, Cybin also has a wholly owned division, called Journey Inc. that offers branded, proprietary products targeting mental wellness, the immune system, detoxification and overall general health and wellness.

Cybin is a mushroom life-sciences company advancing psychedelic and nutraceutical-based products. Cybin is launching psilocybin-based products in jurisdictions where the substance is not banned. Simultaneously, Cybin is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships.

For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://ibn.fm/Cybin

• Deltec recently released investment research concerning COVID-19-related U.S. stimulus package
• Company’s combined expertise comprises more than 150 professionals, including private bankers, certified public accountants, investment advisors, lawyers, trust officers
• Deltec recently recognized as ‘Best Private Bank in the Caribbean 2020’ by Global Banking and Finance Review

As a leading financial hub for the global investment, finance and entrepreneur community, Deltec Bank & Trust offers specialized financial solutions and institutional expertise with the primary goal of creating opportunities for its clients to enhance their wealth. As part of its service offerings, the company recently released a special report (http://ibn.fm/7Ig6O) outlining details of the U.S. government’s $2.2 trillion Coronavirus Aid, Relief, and Economic Security (“CARES”) stimulus package. The timely piece includes commentary concerning the potential effects to US personal incomes should the unemployment insurance benefits be allowed to expire at the end of the month without extension.

Besides offering specialized services that span private, corporate and merchant banking, Deltec moves beyond its core set of services by providing specialized research reports published periodically for the benefit of its clients.

Forming part of Deltec’s global financial hub is the collective experience of more than 150 professionals gleaned from a wide array of backgrounds, including private bankers, certified public accountants, investment advisors, lawyers and trust officers. With the power of their combined experience from some of the world’s largest and most prestigious financial institutions, the professionals at Deltec provide unparalleled expertise in working with complex multi-jurisdictional entities in addition to individuals and families aiming to protect their wealth. The company’s assets under management, administration and custody have risen substantially as a result of the purchase of Société Generale’s private banking business in The Bahamas, growing to over $12 billion as of late 2019 (http://ibn.fm/lZTrN).

Recognized periodically for its outstanding performance and achievements, Deltec recently won the ‘Best Private Bank in the Caribbean 2020’ award for a second time from the Global Banking and Finance Review (http://ibn.fm/s724h). Besides being recognized internationally for strong client relations and highly personalized innovative products, Deltec maintains a strong position at the forefront of the digital banking and fintech revolution with its annual conference focused on disruptive technologies within the financial services industry (http://ibn.fm/BdQSA).

Founded in 1959, Deltec Bank & Trust Ltd. is the flagship company of the Deltec International Group, a diversified independent financial services organization that provides a wide range of financial services that include investment management and research, fund administration, merchant banking, corporate advisory, digital asset solutions and global insurance. Besides providing top-tier services for their diverse range of clientele, Deltec also actively engages with the local community in The Bahamas through its Deltec Initiatives Foundation that aims to empower youth in driving forward positive social impact through the power of the arts, entrepreneurship and education.

For more information, visit the company’s website at www.DeltecBank.com.

NOTE TO INVESTORS: The latest news and updates relating to Deltec are available in the company’s newsroom at http://ibn.fm/Deltec